Ebtehal K. Farrag

Ebtehal K. Farrag

Auto-generated profile, based on publicly available information

Ebtehal K. Farrag

Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Dokki 12622, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Heba ShawkyHeba Shawky
Heba Shawky
DFDalia B. Fayed
Dalia B. Fayed
SESomaia Abd El-Karim
Somaia Abd El-Karim
HRHamdy Rezk
Hamdy Rezk
MEMona Esawy
Mona Esawy
EFEbtehal K. Farrag
Ebtehal K. Farrag

19 September 2023 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
EFEbtehal K. Farrag
Ebtehal K. Farrag
WAWessam M. Aziz
Wessam M. Aziz
SSSylvia E. Shaker
Sylvia E. Shaker
Heba ShawkyHeba Shawky
Heba Shawky
DFDalia B. Fayed
Dalia B. Fayed

24 July 2024 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
SSSylvia E Shaker
Sylvia E Shaker
DFDalia B Fayed
Dalia B Fayed
Heba ShawkyHeba Shawky
Heba Shawky
EFEbtehal K Farrag
Ebtehal K Farrag
Background: This study aimed to assess the herb–drug interactions between crude/silver nanoparticle (SNP)-loaded carob extract (Car, NCar, respectively) and donepezil-HCl (DPZ) and their impact on neurotherapeutic outcomes in a dementia model. Methods: Carob pods were subjected to ethanol extraction, and their phytoconstituents were chromatographically analysed. SNP-loaded extract was synthesized and characterized, and dementia-like symptoms were induced in Wistar rats by repeated dosing with 175 mg/kg AlCl3 for 60 days, after which the animals were treated with Car, NCar, DPZ, and combinations of Car/NCar-DPZ for 30 days. The effect of carob formulations on DPZ bioavailability was in-silico profiled and the herb–drug interactions were mathematically assessed as combination indices. Results: Different formulations significantly improved cognitive/spatial memory functions, restored dysregulated brain redox and cholinergic functions, and markedly inhibited cholinesterase, as reflected by the reduction/absence of amyloid plaques and neurofibrillary tangles. In silico profiling of the major phytoconstituents revealed their non-P-glycoprotein substrate nature and CYP3A4, 2C19, and 2C9 inhibition, which might have improved the oral bioavailability of DPZ. The combination index calculations revealed strong synergy between DPZ and both carob formulations, with the strongest effect exhibited by the DPZ/NCar combination. Conclusion: The co-administration of carob extract/SNPs represents a promising approach for enhancing the neurotherapeutic efficacy of DPZ.